Multi-Center Randomized Control Trial to Study the Effectiveness of Hyperbaric Oxygen for COVID-19 Patients with Moderate to Severe Respiratory Distress

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Covid-19
  • Age: Between 18 - 99 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Positive COVID 19 test or clear clinical diagnosis of COVID-19
    2. Moderate to severe hypoxemia defined by a baseline supplemental oxygen requirement of 6 liters or higher (including high flow oxygenation devices) as measured within the 24 hours before treatment

You may not be eligible for this study if the following are true:

    1. Pregnancy
    2. Untreated pneumothorax
    3. Presence of pneumomediastinum, pneumopericardium, significant subcutaneous emphysema, or pulmonary blebs
    4. Current invasive mechanical ventilation
    5. Current non-invasive mechanical ventilation (e.g., CPAP, BiPAP)
    6. Any participants who will not be stable for transport to the hyperbaric chamber
    7. Those who cannot provide written informed consent



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.